Spine Asia Co (ROCO:6758) Marketable Securities: NT$0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6758 Spine Asia Co Ltd ROCO:6758
80 GF Score
Price NT$29.10
GF Value NT$44.30
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Spine Asia Co Marketable Securities?

Spine Asia Co ROCO:6758 80 Marketable Securities is NT$0.0 Mil as of Jun. 2026. GuruFocus rates ROCO:6758 with a GF Score™ of 80/100 and a GF Value™ of NT$44.30 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Spine Asia Co's Marketable Securities for the quarter that ended in Jun. 2026 was NT$0.0 Mil.

Spine Asia Co  (ROCO:6758) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Spine Asia Co Marketable Securities Related Terms

Spine Asia Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Spine Asia Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spine Asia Co Marketable Securities Chart

Spine Asia Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Spine Asia Co Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:6758
80GF Score
Spine Asia Co Ltd ROCO:6758
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Spine Asia Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of NT$0.0 Mil mean?
Spine Asia Co (ROCO:6758) has a Marketable Securities of NT$0.0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Spine Asia Co and its competitors.
Is Spine Asia Co's Marketable Securities too high?
Spine Asia Co's current Marketable Securities is NT$0.0 Mil. Overall, Spine Asia Co has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spine Asia Co's Marketable Securities compare to ABT and SYK?
Spine Asia Co's Marketable Securities of NT$0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Spine Asia Co and its competitors. Spine Asia Co's current Marketable Securities is NT$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spine Asia Co stock overvalued right now?
Based on GuruFocus' analysis, Spine Asia Co (ROCO:6758) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$44.30, compared to a current price of NT$29.10 — trading 34.3% below its estimated fair value. The current Marketable Securities is NT$0.0 Mil. Spine Asia Co's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Spine Asia Co (ROCO:6758), the current Marketable Securities is NT$0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Spine Asia Co (ROCO:6758) Overvalued in 2026?

Based on GuruFocus' analysis, Spine Asia Co stock appears to be undervalued. The current stock price of NT$29.10 is trading 34.3% below its estimated GF Value™ of NT$44.30. GuruFocus considers Spine Asia Co to be Significantly Undervalued.

Key valuation signals for ROCO:6758:

  • Marketable Securities: NT$0.0 Mil
  • GF Value™: NT$44.30 vs. price of NT$29.10 (34.3% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6758 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Spine Asia Co Business Description

Address No. 80, Section 1, Chenggong Road, 20th Floor, Yonghe District, New Taipei, TWN
Spine Asia Co Ltd is a medical device company. It is engaged in the research, development, manufacturing, and marketing of spinal, implants and instruments. The company offers products such as vigor lumbar peek cage, remond polymer cervical cage, and combo cervical disc cage.
80GF Score

Get the complete analysis for ROCO:6758

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$29.10
Price
NT$44.30
GF Value